在病理生理条件下通过自然产品向铁亡
Daheng Zheng1, Shikai Jin1, Pu-Ste Liu2
1School of Life and Environmental Sciences, Shaoxing University, Shaoxing, Zhejiang, China.
Archives of toxicology
|July 10, 2024
概括
天然产品在调节铁亡,一种与铁和脂质过氧化相关的细胞死亡途径方面表现有前途. 这篇评论探讨了它们在癌症和神经退行等疾病中的治疗潜力.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 铁亡是一种依赖于铁的细胞死亡,其特征是脂质过氧化.
- 它在各种疾病中的作用提供了治疗机会.
- 自然产品是药物发现和重新利用的丰富来源.
研究的目的:
- 审查铁灭的调节机制.
- 探索铁死在各种病理条件中的影响.
- 分析自然产品在调节铁亡中的作用,以获得治疗效益.
主要方法:
- 关于铁亡机制的文献综述.
- 对天然产品与铁亡途径相互作用的分析.
- 在癌症,I / R损伤,神经退行,AKI,肝损伤和心肌病中检查铁亡.
主要成果:
- 铁亡与许多疾病有关,包括癌症,缺血/再输,神经退行性疾病,急性损伤,肝损伤和心肌病.
- 自然产品可以准关键的铁灭细胞调节剂.
- 了解这些相互作用凸显了潜在的治疗策略.
结论:
- 自然产品为针对铁亡的治疗干预提供了一个有希望的途径.
- 通过天然产品调节铁亡可能有助于治疗各种疾病.
- 为了药物开发,需要对铁亡作用者和天然产品相互作用进行进一步的研究.
更多相关视频
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
888
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.5K
相关概念视频
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Electron Transport Chain: Complex I and II
12.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.8K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
